Jonathan C.A. Skipper, PhD

Executive Vice President for Technology Development

I run technology development at the Ludwig Institute, a program that supports all aspects of scientific, clinical and business development required to build additional validation into Ludwig’s scientific discoveries. Enhancing or de-risking Ludwig’s inventions in this way leads to greater opportunities for partnership and ultimately ensures further development of our most promising technologies. Establishing collaborative and licensing relationships with not-for-profit or commercial partners is a critical process in moving Ludwig technologies into the clinic where they might benefit cancer patients. I have completed numerous partnering transactions with biopharma companies, including several Ludwig start-up biotechnology companies that I have been instrumental in establishing, to develop different Ludwig technologies. I am also the Director of the Ludwig San Diego Branch. I received a PhD in Immunology from University College London and completed further research at the University of Virginia and the University of Oxford.


You are now leaving Ludwig Cancer Research's website and are going to a website that is not operated by the association. We are not responsible for the content or availability of linked sites. Do you wish to continue?